| View |
|
DRP-9864-01
|
Vancomycin (As Hydrochloride)
|
Vancin
|
500 mg
|
Lyophilized Powder for IV Infusion
|
ANTIBACTERIAL (GLYCOPEPTIDE)
|
Gufic Biosciences Ltd.
|
India
|
Renewal
|
18 April 2022
|
21 June 2027
|
| View |
|
BRP-040-11
|
Enoxaparin sodium
|
Isohexane 6000
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
BRP-041-09
|
Enoxaparin sodium
|
Isohexane 4000
|
4000 IU anti-Factor Xa (equivalent to 40 mg)/0.4 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|
| View |
|
BRP-041-11
|
Enoxaparin sodium
|
Noxhart 4000
|
4000 IU anti-Factor Xa (equivalent to 40 mg)/0.4 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation)
|
25 April 2022
|
09 December 2025
|
| View |
|
BRP-040-13
|
Enoxaparin sodium
|
Noxhart 6000
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
DRP-9055-01
|
Meropenem (As Trihydrate)
|
Merophil
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
-
|
03 November 2021
|
31 October 2025
|
| View |
|
DRP-3442-07
|
Cefuroxime (as Axetil)
|
None
|
500mg
|
Film Coated Tablet
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial
|
26 October 2021
|
05 November 2025
|
| View |
|
DRP-6722-03
|
Aspirin
|
None
|
80mg
|
Enteric Coated Tablet
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
-
|
26 October 2021
|
16 June 2026
|
| View |
|
DRP-2227-05
|
Naproxen Sodium
|
Unbranded
|
550mg
|
Film Coated Tablet
|
Non-Steroidal Anti-inflammatory Drug (NSAID) [Non-Selective COX Inhibitor]
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
18 August 2023
|
10 September 2028
|
| View |
|
DRP-1369-03
|
Aspirin
|
Asthromed
|
80 mg
|
Enteric-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
03 November 2021
|
17 May 2025
|
| View |
|
DRP-4289-05
|
5% Amino Acids + 5% Sorbitol
|
None
|
Formulation: Each 100 mL contains: Glycerine L-Phenylalanine L-Arginine Hydrochloride L-Leucine L-Lysine Hydrochloride L-Valine L-Isoleucine L-Aspartic Acid L-Histidine HCI, H2O L-Threonine
225 mg 200 mg 100 mg 100 mg 90 mg
760 mg L-Methionine 533 mg L-Alanine 500 mg L-Proline 490 mg L-Serine 430 mg L-Tryptophan 360 mg L-Glutamic Acid 352 mg L-Tyrosine 250 mg L-Cysteine HCI 250 mg Sorbitol 250 mg
75 mg 25 mg
10 mg 5 mg
This CPR is granted following A.0.31 s. 2005.
|
Solution For Intravenous Infusion For Injection
|
I.V. Solution Additives / Nutrient
|
Albert David Limited
|
India
|
Renewal
|
07 April 2022
|
21 November 2027
|
| View |
|
DRP-2167-05
|
Pioglitazone (As Hydrochloride)
|
Pioglizein-15
|
15 mg
|
Tablet
|
Oral Hypoglycemic Agent (Thiazolidinedione)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
19 October 2022
|
13 May 2028
|
| View |
|
DRP-2807-05
|
Pioglitazone Hydrochloride
|
Pioglizein-30
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
14 November 2023
|
22 February 2029
|
| View |
|
DRP-4549-03
|
Cotrimaxozole
|
Urobac
|
960 mg
|
Tablet
|
Antibacterial (Sulfonamide)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
21 July 2023
|
26 July 2028
|
| View |
|
DRP-9475-03
|
Paracetamol + Thiamine (Vitamin B1) + Pyridoxine
(Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Vitagesic
|
500 mg/ 50 mg/ 100 mg/ 100 mcg
|
Film-Coated Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
29 October 2021
|
15 January 2026
|
| View |
|
DRP-4549-04
|
Cotrimoxazole
|
Xolfatrim
|
960 mg
|
Tablet
|
Antibacterial (Sulfonamide)
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Renewal
|
09 August 2023
|
26 July 2028
|
| View |
|
DRP-4496-05
|
Mefenamic Acid
|
Flamigen
|
500 mg
|
Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Automatic Renewal
|
25 July 2023
|
02 July 2028
|
| View |
|
DRP-5390-05
|
Mefenamic Acid
|
Flamigen
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Renewal
|
08 July 2024
|
11 July 2029
|
| View |
|
DRP-10495
|
Aluminum Hydroxide + Magnesium Trisilicate +
Simethicone
|
Alumag Plus
|
250 mg/250 mg/30 mg
|
Tablet
|
-
|
Beacons Pharmaceuticals Pte. Ltd.
|
Singapore
|
Initial
|
08 November 2021
|
08 November 2026
|
| View |
|
DRP-10499
|
Paracetamol
|
Panamol
|
500 mg
|
Tablet
|
Analgesic/Antipyretic
|
Beacons Pharmaceuticals PTE. Ltd.
|
Singapore
|
Initial
|
08 November 2021
|
08 November 2026
|